SE9404289D0 - Controlled release - Google Patents

Controlled release

Info

Publication number
SE9404289D0
SE9404289D0 SE9404289A SE9404289A SE9404289D0 SE 9404289 D0 SE9404289 D0 SE 9404289D0 SE 9404289 A SE9404289 A SE 9404289A SE 9404289 A SE9404289 A SE 9404289A SE 9404289 D0 SE9404289 D0 SE 9404289D0
Authority
SE
Sweden
Prior art keywords
pct
mixture
composition
sec
active material
Prior art date
Application number
SE9404289A
Other languages
English (en)
Other versions
SE518619C2 (sv
SE9404289L (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9404289A priority Critical patent/SE518619C2/sv
Publication of SE9404289D0 publication Critical patent/SE9404289D0/sv
Priority to AT95941306T priority patent/ATE213932T1/de
Priority to BR9509897A priority patent/BR9509897A/pt
Priority to AU42768/96A priority patent/AU4276896A/en
Priority to ES95941306T priority patent/ES2170171T3/es
Priority to DE69525761T priority patent/DE69525761T2/de
Priority to EP95941306A priority patent/EP0790822B1/en
Priority to US08/836,103 priority patent/US5906831A/en
Priority to PCT/SE1995/001479 priority patent/WO1996017597A1/en
Priority to JP51754296A priority patent/JP3487860B2/ja
Priority to CA002207218A priority patent/CA2207218C/en
Publication of SE9404289L publication Critical patent/SE9404289L/sv
Priority to FI972415A priority patent/FI972415A0/sv
Priority to NO972614A priority patent/NO972614D0/no
Publication of SE518619C2 publication Critical patent/SE518619C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
SE9404289A 1994-09-12 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin SE518619C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
CA002207218A CA2207218C (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
EP95941306A EP0790822B1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
AU42768/96A AU4276896A (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
ES95941306T ES2170171T3 (es) 1994-12-09 1995-12-08 Composicion de liberacion controlada que forma una estructura micelar inversa (l2) o una estructura micelar normal (l1).
DE69525761T DE69525761T2 (de) 1994-12-09 1995-12-08 MITTEL MIT GESTEUERTER FREISETZUNG, DIE EINE UMGEKEHRTE MICELLARE (L2) STRUKTUR ODER EINE NORMALE MICELLARE (l1) STRUKTUR BILDEN
AT95941306T ATE213932T1 (de) 1994-12-09 1995-12-08 Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden
US08/836,103 US5906831A (en) 1994-09-12 1995-12-08 Controlled release composition forming a reversed micellar (L2) structure or a normal micellar (L1) structure
BR9509897A BR9509897A (pt) 1994-12-09 1995-12-08 Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal
JP51754296A JP3487860B2 (ja) 1994-12-09 1995-12-08 逆ミセル（ｌ２）構造または正常ミセル（ｌ１）構造を形成する制御放出組成物
NO972614A NO972614D0 (no) 1994-12-09 1997-06-06 Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur
FI972415A FI972415A0 (sv) 1994-12-09 1997-06-06 Kontrollerad frigivningskomposition, som bildar en omvänd micellstruktur(L2) eller en normal micellstruktur(L1)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin

Publications (3)

Publication Number Publication Date
SE9404289D0 true SE9404289D0 (sv) 1994-12-09
SE9404289L SE9404289L (sv) 1996-06-10
SE518619C2 SE518619C2 (sv) 2002-10-29

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9404289A SE518619C2 (sv) 1994-09-12 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin

Country Status (13)

Country Link
US (1) US5906831A (sv)
EP (1) EP0790822B1 (sv)
JP (1) JP3487860B2 (sv)
AT (1) ATE213932T1 (sv)
AU (1) AU4276896A (sv)
BR (1) BR9509897A (sv)
CA (1) CA2207218C (sv)
DE (1) DE69525761T2 (sv)
ES (1) ES2170171T3 (sv)
FI (1) FI972415A0 (sv)
NO (1) NO972614D0 (sv)
SE (1) SE518619C2 (sv)
WO (1) WO1996017597A1 (sv)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
CA2508907A1 (en) 2001-11-08 2003-05-15 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
DE60231549D1 (de) * 2001-12-03 2009-04-23 Dor Biopharma Inc Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US20060083768A1 (en) * 2004-09-28 2006-04-20 Atrium Medical Corporation Method of thickening a coating using a drug
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) * 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
CA2988753A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
ES2462465T5 (es) * 2008-05-21 2018-02-28 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial del sueño no alterado por nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
ES2784914T3 (es) 2015-05-20 2020-10-02 Apeel Tech Inc Composiciones de extractos de plantas y métodos de preparación de las mismas
JP7049245B2 (ja) 2015-09-16 2022-04-06 アピール テクノロジー，インコーポレイテッド 分子コーティングのための前駆体化合物
WO2017100636A1 (en) 2015-12-10 2017-06-15 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
CN109068627B (zh) 2016-01-26 2022-03-18 阿比尔技术公司 用于制备和保存消毒产品的方法
WO2018094269A1 (en) 2016-11-17 2018-05-24 Apeel Technology, Inc. Compositions formed from plant extracts and methods of preparation thereof
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
US11641865B2 (en) 2020-03-04 2023-05-09 Apeel Technology, Inc. Compounds and formulations for protective coatings
US11827591B2 (en) 2020-10-30 2023-11-28 Apeel Technology, Inc. Compositions and methods of preparation thereof
JP2023548536A (ja) * 2020-11-04 2023-11-17 イノレックス インベストメント コーポレイション バイオベースのグリセリルヘプタノエートエステル組成物並びにそれを製造及び使用する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
EP0790822B1 (en) 2002-03-06
ATE213932T1 (de) 2002-03-15
DE69525761D1 (de) 2002-04-11
US5906831A (en) 1999-05-25
WO1996017597A1 (en) 1996-06-13
FI972415A (sv) 1997-06-06
SE518619C2 (sv) 2002-10-29
FI972415A0 (sv) 1997-06-06
EP0790822A1 (en) 1997-08-27
JP3487860B2 (ja) 2004-01-19
AU4276896A (en) 1996-06-26
CA2207218A1 (en) 1996-06-13
JPH10510260A (ja) 1998-10-06
NO972614L (no) 1997-06-06
CA2207218C (en) 2002-02-12
DE69525761T2 (de) 2002-10-24
NO972614D0 (no) 1997-06-06
ES2170171T3 (es) 2002-08-01
SE9404289L (sv) 1996-06-10
BR9509897A (pt) 1997-12-30

Similar Documents

Publication Publication Date Title
SE9404289D0 (sv) Controlled release
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
UY23373A1 (es) Procedimiento para preparar nuevas composiciones analgesicas
KR840006280A (ko) α-시아노-3-페녹시-4-플루오로벤질 2'2-디메틸-3-(β'β-디클로로비닐)-시클로프로판 카복실레이트 함유 유인제의 제조방법
SE9103783D0 (sv) Vaermebestaendig chokladkomposition och foerfarande foer framstaellning daerav
PT81856B (pt) Processo para a preparacao de ingredientes activos a base de 3-(2,2-di-halogenovinil)2,2-dimetil-ciclopropano-carboxilatos de alfa-ciano-3-fenoxibenzilo e de composicoes insecticidas que os contem
KR910000104A (ko) 투명 조성물
ATE99924T1 (de) Amphipatische emulgiermittel enthaltende emulsionzusammensetzungen.
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
NO952575L (no) Flytende vanillinblanding, dens fremstilling og anvendelse
DK0711115T3 (da) Smøremateriale med lavt fedtindhold.
FI113739B (sv) Olja-i-vatten -emulsioner som mikrobisid (biosid) substituter i vatten innehållande system
EA200300630A1 (ru) Жидкая композиция для жарки
KR920016021A (ko) 동물의 발육 촉진 또는 개선 사료 및 방법
ES2151710T3 (es) Soportes impregnados con una composicion desinfectante.
KR930002268A (ko) 플라이 애쉬(Fly Ash)와 모래를 혼합한 시멘트 조성물
KR920007538A (ko) 벤푸레세이트 및 다임론을 기재로 하는 제초 조성물
KR920017956A (ko) 폐수처리용 미생물제제
KR870008512A (ko) 식물 생장 조절용 조성물
KR920021694A (ko) 친수성 무공해 광택제의 조성방법
KR870008584A (ko) 피임제 조성물
AR001341A1 (es) Composición coadyuvante líquida de uso agricola.

Legal Events

Date Code Title Description
NUG Patent has lapsed